Background
==========

To cover the genetic diversity of HIV-1 among Asian countries, three mosaic HIV-1 DNA vaccines encompassing the gag gene derived from HIV-1 CRF01_AE and Asian HIV-1 subtype B were constructed and tested for immunogenicity in Balb/c mice.

Methods
=======

Full-length gag sequences of 1.5 kb derived from 156 CRF01_AE and 72 Asian HIV-1 subtype B were computerized to generate 3 representative mosaic Asian HIV-1 *gag*genes. The mosaic *gag*genes were RNA-optimized and cloned into pCMVkan expression vector. Mice were immunized by intradermal (ID) and needle-free injector (NF) using 100 and 50 μg, respectively, of the 3 mosaic-gag mixtures. The vaccinations were performed on days 0, 14 and 28. An additional group received 5-million pfu vaccinia-AE boost on day 42. Mice were sacrificed on day 35 (DNA alone) and day 49 (DNA prime/vaccinia boost) and the immunogenicity was assessed by anti-p24 antibody and IFN-gamma ELISpot assays. Both HIV-1 AE- and B-peptide pools were used separately to stimulate splenocytes.

Results
=======

All mice showed anti-p24 antibody responses of at least 1:10,000. For ELISpot assay, with the AE-peptide pool stimulation, the responses (median spots (range)) were 430 (291--643) and 953 (641--1206) for ID and NF groups, respectively. Whereas with the B-peptide pool stimulation, the responses were 560 (411--776) and 1151 (711--1352) for the ID and NF groups, respectively. The NF group showed statistically higher cellular immune responses testing either peptide pools (p = 0.0043 for AE & B, Mann-Whitney test). The prime/boost strategy using AE vaccinia virus gave much better responses of 1756(1062--2293) when stimulated with the AE-pool (p = 0.0087) but no increase in B-peptide responses (930 spots (679--1270)).

Conclusion
==========

Our results suggest that the mosaic Asian HIV-1 DNA vaccine was immunogenic and could induce both humoral- and cell-mediated immune responses with appropriate immunization modification, i.e., using NF and prime/boost strategies.
